PodParley PodParley
PodParley
Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer episode artwork

EPISODE · Feb 2, 2026 · 2 MIN

Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer

from TheBrief.Health · host TheBrief.Health

Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.

What this episode covers

Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.

NOW PLAYING

Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer

0:00 2:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 2 minutes long.

When was this TheBrief.Health episode published?

This episode was published on February 2, 2026.

What is this episode about?

Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.

Can I download this TheBrief.Health episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!